Early detection and measurement of urothelial tumors in mice

Urology

Volumn 67, Issue 6, 2006, Pages 1309-1314

  Johnson, Aimee M ^a   Conover, David L ^a   Huang, Jiaoti ^a   Messing, Edward M ^a   Ning, Ruola ^a   O'Connell, Mary J ^a   Rossi, M Adrian ^a   Sun, Tung Tien ^b   Wood, Ronald W ^a   Wu, Xue Ru ^b   Reeder, Jay E ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM; IOHEXOL; UROPLAKIN; VIRUS LARGE T ANTIGEN;

ALGORITHM; ANESTHESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; BLADDER TUMOR; CANCER DIAGNOSIS; CANCER GROWTH; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DATA ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; FEMALE; HEMATURIA; HISTOLOGY; IODINATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; SIMIAN VIRUS 40; THREE DIMENSIONAL IMAGING; TRANSGENIC MOUSE; TUMOR VOLUME; URINARY EXCRETION; URINARY TRACT; UROGENITAL TRACT TUMOR;

ANIMALS; EARLY DIAGNOSIS; FEMALE; MALE; MICE; MICE, TRANSGENIC; URINARY BLADDER NEOPLASMS; UROTHELIUM;

EID: 33744515018     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2005.12.011     Document Type: Article

References (28)

1. American Cancer Society. Cancer Facts and Figures 2004 (2004), American Cancer Society, Atlanta
2. Ito N., Hiasa Y., Tamai A., et al. Histogenesis of urinary bladder tumors induced by N-butyl-N-(4-hydroxybutyl)nitrosamine in rats. Gann 60 (1969) 401-410
3. Okada M., and Ishidate M. Metabolic fate of N-n-butyl-N-(4-hydroxybutyl)-nitrosamine and its analogues. selective induction of urinary bladder tumours in the rat. Xenobiotica 7 (1977) 11-24
4. McCormick D.L., Ronan S.S., Becci P.J., et al. Influence of total dose and dose schedule on induction of urinary bladder cancer in the mouse by N-butyl-N-(4-hydroxybutyl) nitrosamine. Carcinogenesis 2 (1981) 251-254
5. Iida K., Ito K., Kumagai Y., et al. Nrf2 is essential for the chemopreventive efficacy of oltipraz against urinary bladder carcinogenesis. Cancer Res 64 (2004) 6424-6431
6. Benedict W.F., Tao Z., Kim Z.S., et al. Intravesical Ad-IFNalpha causes marked regression of human bladder cancer growing orthotopically in nude mice and overcomes resistance to IFN-alpha protein. Mol Therapy 10 (2004) 525-532
7. Luo Y., Chen X., and O'Donnel M.A. Use of prostate specific antigen to measure bladder tumor growth in a mouse orthotopic model. J Urol 172 (2004) 2414-2420
8. Muramaki M., Miyake H., Hara I., et al. Synergistic inhibition of tumor growth and metastasis by combined treatment with TNP-470 and gemcitabine in a human bladder cancer KoTCC-1 model. J Urol 172 (2004) 1485-1489
9. Wu X., Esuvaranathan K., and Mahendran R. Monitoring the response of orthotopic bladder tumors to granulocyte macrophage colony-stimulating factor therapy using the prostate-specific antigen gene as a reporter. Clin Cancer Res 10 (2004) 6977-6984
10. Zhang Z.T., Pak J., Shapiro E., et al. Urothelium-specific expression of an oncogene in transgenic mice induced the formation of carcinoma in situ and invasive transitional cell carcinoma. Cancer Res 59 (1999) 3512-3517
11. Zhang Z.T., Pak J., Huang H.Y., et al. Role of Ha-ras activation in superficial papillary pathway of urothelial tumor formation. Oncogene 20 (2001) 1973-1980
12. Cheng J., Huang H., Pak J., et al. Allelic loss of p53 gene is associated with genesis and maintenance, but not invasion, of mouse carcinoma in situ of the bladder. Cancer Res 63 (2003) 179-185
13. Gao J., Huang H.Y., Pak J., et al. p53 deficiency provokes urothelial proliferation and synergizes with activated Ha-ras in promoting urothelial tumorigenesis. Oncogene 23 (2004) 687-696
14. Klein R.D., Van Pelt C.S., de la Cerda J., et al. Transitional cell hyperplasia and carcinomas in urinary bladders of transgenic mice with keratin 5 promoter-driven cyclooxygenase-2 overexpression. Cancer Res 65 (2005) 1808-1813
15. Li Q., Karam S.M., and Gordon J.I. Simian virus 40 T antigen-induced amplification of pre-parietal cells in transgenic mice. J Biol Chem 270 (1995) 15777-15788
16. Wood R., Eichel L., Messing E.M., et al. Automated noninvasive measurement of cyclophosphamide-induced changes in murine voiding frequency and volume. J Urol 165 (2001) 653-659
17. Valenstein E.S., Cox V.C., and Kakolewski J.W. Polydipsia elicited by the synergistic action of a saccharin and glucose solution. Science 157 (1967) 552-554
18. Ning R., Tang X., Conover D., et al. Flat panel detector-based cone beam computed tomography with a circle-plus-two-arcs data acquisition orbit. preliminary phantom study. Med Phys 30 (2004) 1694-1705
19. Conover D.L., Ning R., Yu Y., et al. Small animal imaging using a flat panel detector-based cone beam computed tomography (FPD-CBCT) imaging system. Proc SPIE Med Imaging 5745 (2005) 307-318
20. Messing E.M., Young T.B., Hunt V.B., et al. Hematuria home screening. repeat testing results. J Urol 154 (1995) 57-61
21. Greene L.F., and O'Shaughnessy E.J. Study of five hundred patients with asymptomatic microhematuria. JAMA 161 (1956) 610-613
22. Carson III C.C., Segura J.W., and Greene L.F. Clinical importance of microhematuria. JAMA 241 (1979) 149-150
23. Britton P.J., Dowell A.C., and Whalen P. Dipstick hematuria and bladder cancer in men over 60. results of a community study. BMJ 299 (1989) 1010-1012
24. Messing E.M., Young T.B., Hunt V.B., et al. Home screening for hematuria. results of a multi-clinic study. J Urol 148 (1992) 289-292
25. Leung Y.Y., Schwarz E.M., Silvers C.R., et al. Uroflow in murine urethritis. Urology 64 (2004) 378-382
26. Arnold D.L., Moodie C.A., Grice H.C., et al. Long-term toxicity of ortho-toluenesulfonamide and sodium saccharin in the rat. Tox Appl Pharm 52 (1980) 113-152
27. Langheinrich A.C., Wienhard J., Vormann S., et al. Analysis of the fetal placental vascular tree by x-ray micro-computed tomography. Placenta 25 (2004) 95-100
28. Marxen M., Thornton M.M., Chiarot C.B., et al. MicroCT scanner performance and considerations for vascular specimen imaging. Med Phys 31 (2004) 305-313